We serve Chemical Name:3-bromo-1-methyl-6-nitroindazole CAS:74209-32-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-bromo-1-methyl-6-nitroindazole
CAS.NO:74209-32-8
Synonyms:3-Bromo-1-methyl-6-nitro-1H-indazole;3-Brom-1-methyl-6-nitro-1H-indazol
Molecular Formula:C8H6BrN3O2
Molecular Weight:256.05600
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:63.64000
Exact Mass:254.96400
LogP:2.76720
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Bromo-1-methyl-6-nitro-1H-indazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Brom-1-methyl-6-nitro-1H-indazol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Bromo-1-methyl-6-nitro-1H-indazole Use and application,3-Brom-1-methyl-6-nitro-1H-indazol technical grade,usp/ep/jp grade.
Related News: The CTSuccess service uses Catalent��s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics. 3-bromo-1-methyl-6-nitroindazole manufacturer Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs. 3-bromo-1-methyl-6-nitroindazole supplier Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs. 3-bromo-1-methyl-6-nitroindazole vendor International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. 3-bromo-1-methyl-6-nitroindazole factory International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.
